Evidence suggests that its expression is related to the depletion of CD4+ T cells in HIV-1 infection [19], tumor progression in several oncologic diseases through the inhibition of CD4+ T cell differentiation into mature subsets, and tumor cell resistance to the inhibitory control of PD-1 [20, 21]. Here, CD4 is linked to neoplasm.